Camber Capital Management’s Biolase, Inc. BIOL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-427
| Closed | -$3.21M | – | 37 |
|
|
2017
Q3 | $3.21M | Hold |
427
| – | – | 0.2% | 22 |
|
|
2017
Q2 | $5.17M | Hold |
427
| – | – | 0.25% | 30 |
|
|
2017
Q1 | $7.2M | Hold |
427
| – | – | 0.29% | 26 |
|
|
2016
Q4 | $7.47M | Buy |
+427
| New | +$7.47M | 0.39% | 29 |
|
|
2016
Q3 | – | Sell |
-427
| Closed | -$6.24M | – | 40 |
|
|
2016
Q2 | $6.24M | Hold |
427
| – | – | 0.3% | 36 |
|
|
2016
Q1 | $6.99M | Hold |
427
| – | – | 0.41% | 36 |
|
|
2015
Q4 | $4.49M | Hold |
427
| – | – | 0.29% | 36 |
|
|
2015
Q3 | $4.8M | Hold |
427
| – | – | 0.41% | 38 |
|
|
2015
Q2 | $9.28M | Sell |
427
-164
| -28% | -$3.56M | 0.63% | 32 |
|
|
2015
Q1 | $11.3M | Buy |
591
+147
| +33% | +$2.81M | 0.81% | 28 |
|
|
2014
Q4 | $14.6M | Buy |
444
+227
| +105% | +$7.46M | 0.97% | 26 |
|
|
2014
Q3 | $6.76M | Hold |
217
| – | – | 0.64% | 31 |
|
|
2014
Q2 | $5.97M | Hold |
217
| – | – | 0.39% | 37 |
|
|
2014
Q1 | $6.54M | Hold |
217
| – | – | 0.51% | 35 |
|
|
2013
Q4 | $7.65M | Hold |
217
| – | – | 0.67% | 29 |
|
|
2013
Q3 | $5.13M | Buy |
+217
| New | +$5.13M | 0.54% | 29 |
|